Showing 1,041 - 1,060 results of 118,676 for search '(( a mean decrease ) OR ( 5 ((((ng decrease) OR (a decrease))) OR (we decrease)) ))', query time: 1.60s Refine Results
  1. 1041
  2. 1042

    Fig 5 Data. by Kevin D. Gaitonde (15411707)

    Published 2023
    “…We observed a marked decrease in nocturnal locomotion of <i>Opn5</i><sup><i>cre</i></sup><i>; Gnas</i><sup><i>fl/fl</i></sup> mice at both 28°C and 22°C, but no overall differences in energy expenditure, respiratory exchange, or food and water consumption. …”
  3. 1043
  4. 1044
  5. 1045
  6. 1046
  7. 1047

    Descriptives of the study sample, N = 451. by Orrin D. Ware (14829115)

    Published 2025
    “…Most of the sample self-identified as female/woman (77.6%) and White (82.7%). A slight mean decrease was identified in scores for the Stigma of Suicide Scale Short Form: Overall and the Stigma of Suicide Scale Short Form: Stigma Subscale from pre-performance to post-performance. …”
  8. 1048
  9. 1049
  10. 1050
  11. 1051
  12. 1052
  13. 1053
  14. 1054

    MVEC microvessel formation is restricted in hydrogels exhibiting increased stiffness or decreased concentration of adhesive peptides. by Rebecca A. Scott (488956)

    Published 2020
    “…An unpaired student’s t-test detect statistical significance, *p<0.05 for 7.5 wt% hydrogels containing 3 mM RGD relative to either (<b>A, C-F</b>) 15wt% hydrogels containing 3 mM RGD or (<b>G, I-L</b>) 7.5wt% hydrogels containing 1 mM RGD.…”
  15. 1055

    FLCN-deficiency leads to decreased Rho activity in sub-confluent cells and delays in wound closure. by Doug A. Medvetz (300145)

    Published 2013
    “…<b>B)</b> Rho activity was measured using a Rhotekin binding assay at 70% confluence. The FLCN-null UOK257 cells had a 2.5-fold decrease in active Rho levels (Rho GTP) compared to the FLCN re-expressing UOK257-2 cells (n = 3, p<0.05). …”
  16. 1056
  17. 1057
  18. 1058

    Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines. by David Herrero Martín (286820)

    Published 2013
    “…<p>Rh4 and RMS13 cells were treated for 24 hours (A) and 48 hours (B) with different concentrations of fenretinide (0.5–1–5 µM, as indicated). …”
  19. 1059
  20. 1060